These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

306 related items for PubMed ID: 7352712

  • 1. Treatment of tularemia, including pulmonary tularemia, with gentamicin.
    Mason WL, Eigelsbach HT, Little SF, Bates JH.
    Am Rev Respir Dis; 1980 Jan; 121(1):39-45. PubMed ID: 7352712
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Comparative study of the effectiveness of amikacin and streptomycin in experimental tularemia].
    Tynkevich NK, Pavlovich NV, Ryzhko IV.
    Antibiot Khimioter; 1990 Aug; 35(8):35-7. PubMed ID: 2264751
    [Abstract] [Full Text] [Related]

  • 4. Tularemia: treatment failures with outpatient use of ceftriaxone.
    Cross JT, Jacobs RF.
    Clin Infect Dis; 1993 Dec; 17(6):976-80. PubMed ID: 8110955
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. In vitro susceptibility of isolates of Francisella tularensis types A and B from North America.
    Urich SK, Petersen JM.
    Antimicrob Agents Chemother; 2008 Jun; 52(6):2276-8. PubMed ID: 18411318
    [Abstract] [Full Text] [Related]

  • 7. Needle-Free Delivery of Acetalated Dextran-Encapsulated AR-12 Protects Mice from Francisella tularensis Lethal Challenge.
    Hoang KV, Curry H, Collier MA, Borteh H, Bachelder EM, Schlesinger LS, Gunn JS, Ainslie KM.
    Antimicrob Agents Chemother; 2016 Apr; 60(4):2052-62. PubMed ID: 26787696
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Antimicrobial Susceptibility of Francisella tularensis Isolates in the United States, 2009-2018.
    Choat J, Young J, Petersen JM, Dietrich EA.
    Clin Infect Dis; 2024 Jan 31; 78(Suppl 1):S4-S6. PubMed ID: 38294116
    [Abstract] [Full Text] [Related]

  • 11. Susceptibility pattern of Scandinavian Francisella tularensis isolates with regard to oral and parenteral antimicrobial agents.
    Scheel O, Hoel T, Sandvik T, Berdal BP.
    APMIS; 1993 Jan 31; 101(1):33-6. PubMed ID: 8384458
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. In vitro susceptibility of Francisella tularensis to fluoroquinolones and treatment of tularemia with norfloxacin and ciprofloxacin.
    Syrjälä H, Schildt R, Räisäinen S.
    Eur J Clin Microbiol Infect Dis; 1991 Feb 31; 10(2):68-70. PubMed ID: 1864276
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Detection of persistent resistance to antibacterial drugs in various strains of Francisella tularensis].
    Pavlovich NV, Tynkevich NK, Ryzhko IV, Danilevskaia GI.
    Antibiot Khimioter; 1992 Oct 31; 37(10):29-31. PubMed ID: 1296530
    [Abstract] [Full Text] [Related]

  • 16. Antimicrobial susceptibilities of Francisella tularensis subsp. holarctica strains isolated from humans in the Central Anatolia region of Turkey.
    Yesilyurt M, Kiliç S, Celebi B, Celik M, Gül S, Erdogan F, Ozel G.
    J Antimicrob Chemother; 2011 Nov 31; 66(11):2588-92. PubMed ID: 21856791
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Mesoporous Silica Nanoparticles with pH-Sensitive Nanovalves for Delivery of Moxifloxacin Provide Improved Treatment of Lethal Pneumonic Tularemia.
    Li Z, Clemens DL, Lee BY, Dillon BJ, Horwitz MA, Zink JI.
    ACS Nano; 2015 Nov 24; 9(11):10778-89. PubMed ID: 26435204
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.